Article

Rapid Identification of Druggable Targets and the Power of the Phenotype SIMulator for Effective Drug Repurposing in COVID-19

2022-08-11

Abstract excerpt

The current, rapidly diversifying pandemic has accelerated the need for efficient and effective identification of potential drug candidates for COVID-19. Knowledge on host-immune response to SARS-CoV-2 infection, however, remains limited with few drugs approved to date. Viable strategies and tools are rapidly arising to address this, especially with repurposing of existing drugs offering significant promise. Here...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4f8d5fe4-e98d-525b-8d2a-28ada276aa81
DOI: 10.2139/ssrn.4187487

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Rapid Identification of Druggable Targets and the Power of the Phenotype SIMulator for Effective Drug Repurposing in COVID-19DOI 10.2139/ssrn.4187487Read

Modeling COVID-19 disease biology to identify drug treatment candidatesSemantic proximity Read

Mechanistic modeling of the SARS-CoV-2 disease mapSemantic proximity Read

A genetically based computational drug repurposing framework for rapid identification of candidate compounds: application to COVID-19Semantic proximity Read

Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approachSemantic proximity Read

Mechanistic modeling of the SARS-CoV-2 disease mapSemantic proximity Read

A Quantitative Systems Pharmacology Model of the Pathophysiology and Treatment of COVID-19 Predicts Optimal Timing of Pharmacological InterventionsSemantic proximity Read

Translating GWAS Findings to Inform Drug Repositioning Strategies for COVID-19 TreatmentSemantic proximity Read

In silico Drug Repurposing to combat COVID-19 based on Pharmacogenomics of Patient Transcriptomic DataSemantic proximity Read

A Connectivity Map-Based Drug Repurposing Study and Integrative Analysis of Transcriptomic Profiling of SARS-CoV-2 InfectionSemantic proximity Read

COVID-19 virtual patient cohort reveals immune mechanisms driving disease outcomesSemantic proximity Read

A systems‐level study reveals host‐targeted repurposable drugs against SARS‐CoV‐2 infectionSemantic proximity Read

Mechanistic modeling of the SARS-CoV-2 and immune system interplay unravels design principles for diverse clinicopathological outcomesSemantic proximity Read